ID

24630

Description

Bortezomib and High-dose Melphalan at Myeloma Relapse; ODM derived from: https://clinicaltrials.gov/show/NCT00508209

Link

https://clinicaltrials.gov/show/NCT00508209

Keywords

Versions (1)
  1. 8/10/17 8/10/17 -
Uploaded on

August 10, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00508209

English

Eligibility Multiple Myeloma NCT00508209

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
first relapse after asct
Description

Autologous hematopoietic stem cell transplant Status post | First Relapse

Data type

boolean

Alias
UMLS CUI [1,1]
C2193200
UMLS CUI [1,2]
C0231290
UMLS CUI [2]
C4054953
symptomatic myeloma
Description

Myeloma Symptomatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0231220
more than 2,0 x 10^6 cd34+ stem cells / kg bodyweight in the freezer for stem cell support
Description

Stem cells CD34 positive Available | Stem cells Support

Data type

boolean

Alias
UMLS CUI [1,1]
C0038250
UMLS CUI [1,2]
C0882849
UMLS CUI [1,3]
C0470187
UMLS CUI [2,1]
C0038250
UMLS CUI [2,2]
C1521721
signed informed consent given prior to any study related activities have been performed
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
age > 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
allogeneic transplantation scheduled as a part of the treatment
Description

Homologous Transplantation Scheduled

Data type

boolean

Alias
UMLS CUI [1,1]
C0040739
UMLS CUI [1,2]
C0205539
expected survival of less than one month.
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
performance status (who) > 3
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
neuropathy > grade 3 (neurological symptoms interfering with adl)
Description

Neuropathy CTCAE Grades | Neurologic Symptoms Interfere with Activities of Daily Living

Data type

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
UMLS CUI [2,1]
C0235031
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0001288
non-secreting myeloma
Description

Non-secretory myeloma

Data type

boolean

Alias
UMLS CUI [1]
C0456845
other concurrent disease making bortezomib treatment unsuitable
Description

Comorbidity | Bortezomib Inappropriate

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2,1]
C1176309
UMLS CUI [2,2]
C1548788
positive pregnancy test (only applicable for women with childbearing potential)
Description

Childbearing Potential Pregnancy test positive

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0240802
has known or suspected hypersensitivity or intolerance to melphalan, dexamethasone, boron, mannitol, or heparin, if an indwelling catheter is used
Description

Melphalan allergy | Melphalan allergy Suspected | Intolerance to Melphalan | Intolerance to Melphalan Suspected | Dexamethasone allergy | Dexamethasone allergy Suspected | Intolerance to Dexamethasone | Intolerance to Dexamethasone Suspected | Hypersensitivity Boron | Hypersensitivity Boron Suspected | Intolerance to Boron | Intolerance to Boron Suspected | Mannitol allergy | Mannitol allergy Suspected | Intolerance to Mannitol | Intolerance to Mannitol Suspected | Heparin allergy | Heparin allergy Suspected | Intolerance Heparin | Intolerance to Heparin Suspected | Indwelling Catheter Use of

Data type

boolean

Alias
UMLS CUI [1]
C0570673
UMLS CUI [2,1]
C0570673
UMLS CUI [2,2]
C0750491
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0025241
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0025241
UMLS CUI [4,3]
C0750491
UMLS CUI [5]
C0571611
UMLS CUI [6,1]
C0571611
UMLS CUI [6,2]
C0750491
UMLS CUI [7,1]
C1744706
UMLS CUI [7,2]
C0011777
UMLS CUI [8,1]
C1744706
UMLS CUI [8,2]
C0011777
UMLS CUI [8,3]
C0750491
UMLS CUI [9,1]
C0020517
UMLS CUI [9,2]
C0006030
UMLS CUI [10,1]
C0020517
UMLS CUI [10,2]
C0006030
UMLS CUI [10,3]
C0750491
UMLS CUI [11,1]
C1744706
UMLS CUI [11,2]
C0006030
UMLS CUI [12,1]
C1744706
UMLS CUI [12,2]
C0006030
UMLS CUI [12,3]
C0750491
UMLS CUI [13]
C0571922
UMLS CUI [14,1]
C0571922
UMLS CUI [14,2]
C0750491
UMLS CUI [15,1]
C1744706
UMLS CUI [15,2]
C0024730
UMLS CUI [16,1]
C1744706
UMLS CUI [16,2]
C0024730
UMLS CUI [16,3]
C0750491
UMLS CUI [17]
C0571776
UMLS CUI [18,1]
C0571776
UMLS CUI [18,2]
C0750491
UMLS CUI [19,1]
C1744706
UMLS CUI [19,2]
C0019134
UMLS CUI [20,1]
C1744706
UMLS CUI [20,2]
C0019134
UMLS CUI [20,3]
C0750491
UMLS CUI [21,1]
C0007439
UMLS CUI [21,2]
C1524063
uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrolment, new york heart association (nyha) class iii or iv heart failure (attachment 6, nyha classification of cardiac disease), uncontrolled angina, clinically significant pericardial disease, or cardiac amyloidosis
Description

Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Heart failure New York Heart Association Classification | Angina Pectoris Uncontrolled | Disorder of pericardium | Cardiac amyloidosis

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0027051
UMLS CUI [4,1]
C0018801
UMLS CUI [4,2]
C1275491
UMLS CUI [5,1]
C0002962
UMLS CUI [5,2]
C0205318
UMLS CUI [6]
C0265122
UMLS CUI [7]
C0268407
history of hypotension or has decreased blood pressure (sitting systolic blood pressure [sbp] <= 100 mmhg and/or sitting diastolic blood pressure [dbp] <= 60 mmhg)
Description

Hypotension | Decreased Blood Pressure | Sitting systolic blood pressure | Sitting diastolic blood pressure

Data type

boolean

Alias
UMLS CUI [1]
C0020649
UMLS CUI [2]
C2917141
UMLS CUI [3]
C1319893
UMLS CUI [4]
C1319894
serious medical or psychiatric illness likely to interfere with participation in this clinical study
Description

Illness Serious Interferes with Study Subject Participation Status | Serious mental illness Interferes with Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C3841614
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2348568
have received an experimental drug or used an experimental medical device within 4 weeks prior to inclusion into the study
Description

Investigational New Drugs | Investigational Medical Device

Data type

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C2346570
Back to the top of the page

Similar models

Eligibility Multiple Myeloma NCT00508209

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Autologous hematopoietic stem cell transplant Status post | First Relapse
Item
first relapse after asct
boolean
C2193200 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
C4054953 (UMLS CUI [2])
Myeloma Symptomatic
Item
symptomatic myeloma
boolean
C0026764 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Stem cells CD34 positive Available | Stem cells Support
Item
more than 2,0 x 10^6 cd34+ stem cells / kg bodyweight in the freezer for stem cell support
boolean
C0038250 (UMLS CUI [1,1])
C0882849 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0038250 (UMLS CUI [2,1])
C1521721 (UMLS CUI [2,2])
Informed Consent
Item
signed informed consent given prior to any study related activities have been performed
boolean
C0021430 (UMLS CUI [1])
Age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Homologous Transplantation Scheduled
Item
allogeneic transplantation scheduled as a part of the treatment
boolean
C0040739 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
Life Expectancy
Item
expected survival of less than one month.
boolean
C0023671 (UMLS CUI [1])
WHO performance status scale
Item
performance status (who) > 3
boolean
C1298650 (UMLS CUI [1])
Neuropathy CTCAE Grades | Neurologic Symptoms Interfere with Activities of Daily Living
Item
neuropathy > grade 3 (neurological symptoms interfering with adl)
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0235031 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0001288 (UMLS CUI [2,3])
Non-secretory myeloma
Item
non-secreting myeloma
boolean
C0456845 (UMLS CUI [1])
Comorbidity | Bortezomib Inappropriate
Item
other concurrent disease making bortezomib treatment unsuitable
boolean
C0009488 (UMLS CUI [1])
C1176309 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
Childbearing Potential Pregnancy test positive
Item
positive pregnancy test (only applicable for women with childbearing potential)
boolean
C3831118 (UMLS CUI [1,1])
C0240802 (UMLS CUI [1,2])
Melphalan allergy | Melphalan allergy Suspected | Intolerance to Melphalan | Intolerance to Melphalan Suspected | Dexamethasone allergy | Dexamethasone allergy Suspected | Intolerance to Dexamethasone | Intolerance to Dexamethasone Suspected | Hypersensitivity Boron | Hypersensitivity Boron Suspected | Intolerance to Boron | Intolerance to Boron Suspected | Mannitol allergy | Mannitol allergy Suspected | Intolerance to Mannitol | Intolerance to Mannitol Suspected | Heparin allergy | Heparin allergy Suspected | Intolerance Heparin | Intolerance to Heparin Suspected | Indwelling Catheter Use of
Item
has known or suspected hypersensitivity or intolerance to melphalan, dexamethasone, boron, mannitol, or heparin, if an indwelling catheter is used
boolean
C0570673 (UMLS CUI [1])
C0570673 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0025241 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0025241 (UMLS CUI [4,2])
C0750491 (UMLS CUI [4,3])
C0571611 (UMLS CUI [5])
C0571611 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
C1744706 (UMLS CUI [7,1])
C0011777 (UMLS CUI [7,2])
C1744706 (UMLS CUI [8,1])
C0011777 (UMLS CUI [8,2])
C0750491 (UMLS CUI [8,3])
C0020517 (UMLS CUI [9,1])
C0006030 (UMLS CUI [9,2])
C0020517 (UMLS CUI [10,1])
C0006030 (UMLS CUI [10,2])
C0750491 (UMLS CUI [10,3])
C1744706 (UMLS CUI [11,1])
C0006030 (UMLS CUI [11,2])
C1744706 (UMLS CUI [12,1])
C0006030 (UMLS CUI [12,2])
C0750491 (UMLS CUI [12,3])
C0571922 (UMLS CUI [13])
C0571922 (UMLS CUI [14,1])
C0750491 (UMLS CUI [14,2])
C1744706 (UMLS CUI [15,1])
C0024730 (UMLS CUI [15,2])
C1744706 (UMLS CUI [16,1])
C0024730 (UMLS CUI [16,2])
C0750491 (UMLS CUI [16,3])
C0571776 (UMLS CUI [17])
C0571776 (UMLS CUI [18,1])
C0750491 (UMLS CUI [18,2])
C1744706 (UMLS CUI [19,1])
C0019134 (UMLS CUI [19,2])
C1744706 (UMLS CUI [20,1])
C0019134 (UMLS CUI [20,2])
C0750491 (UMLS CUI [20,3])
C0007439 (UMLS CUI [21,1])
C1524063 (UMLS CUI [21,2])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Severe | Myocardial Infarction | Heart failure New York Heart Association Classification | Angina Pectoris Uncontrolled | Disorder of pericardium | Cardiac amyloidosis
Item
uncontrolled or severe cardiovascular disease including myocardial infarction within 6 months of enrolment, new york heart association (nyha) class iii or iv heart failure (attachment 6, nyha classification of cardiac disease), uncontrolled angina, clinically significant pericardial disease, or cardiac amyloidosis
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0027051 (UMLS CUI [3])
C0018801 (UMLS CUI [4,1])
C1275491 (UMLS CUI [4,2])
C0002962 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0265122 (UMLS CUI [6])
C0268407 (UMLS CUI [7])
Hypotension | Decreased Blood Pressure | Sitting systolic blood pressure | Sitting diastolic blood pressure
Item
history of hypotension or has decreased blood pressure (sitting systolic blood pressure [sbp] <= 100 mmhg and/or sitting diastolic blood pressure [dbp] <= 60 mmhg)
boolean
C0020649 (UMLS CUI [1])
C2917141 (UMLS CUI [2])
C1319893 (UMLS CUI [3])
C1319894 (UMLS CUI [4])
Illness Serious Interferes with Study Subject Participation Status | Serious mental illness Interferes with Study Subject Participation Status
Item
serious medical or psychiatric illness likely to interfere with participation in this clinical study
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C3841614 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
Investigational New Drugs | Investigational Medical Device
Item
have received an experimental drug or used an experimental medical device within 4 weeks prior to inclusion into the study
boolean
C0013230 (UMLS CUI [1])
C2346570 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial